Vendor, Albuquerque, NM
Lovelace Biomedical Research Institute
UEI MBT9RXJJ7428, CAGE 3MMH4
55 awards and $21,701,637 obligated between January 9, 2024 and September 25, 2026, 93% under full and open competition, against 10.4 offers on average where reported. 3 of the awards trace back to a SAM.gov solicitation on this site.
Sells to
Awarding agencies by dollars.
| Food and Drug Administration | $12,603,062 |
| Office of Assistant Secretary for Preparedness and Response | $6,358,167 |
| National Institutes of Health | $2,472,941 |
| Defense Health Agency | $267,467 |
| Department of the Army | -$0 |
Industries
NAICS on the awards, by dollars.
| Testing Laboratories and ServicesNAICS 541380 | $9,602,162 |
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $6,645,065 |
| Other Scientific and Technical Consulting ServicesNAICS 541690 | $3,017,553 |
| Professional, Scientific, and Technical ServicesNAICS 541712 | $2,778,555 |
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $754,163 |
| InformationNAICS 511210 | $267,467 |
| Professional, Scientific, and Technical ServicesNAICS 541711 | -$1,363,328 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 51 |
| Not Competed | 2 |
| Not Competed Under SAP | 1 |
| Competed Under SAP | 1 |
| Delivery Order | 36 |
| Purchase Order | 3 |
| Definitive Contract | 2 |
Hear when Lovelace Biomedical Research Institute wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts Lovelace Biomedical Research Institute holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 9
- Obligated so far
- $18,766,723
- Soonest
- February 22, 2027
The 9 contracts, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling testing laboratories and services to Food and Drug Administration, by dollars.
| Ama Analytical Services, Inc.Lanham, MD | $850,533 |
| Litron Laboratories Ltd.Rochester, NY | $176,890 |
| Aoac International, Inc. A/K/A Aoac InternationalRockville, MD | $153,080 |
| Regents of the University of MinnesotaMorris, MN | $150,000 |
| 28BIO, Inc.Metairie, LA | $143,021 |
| Element Materials Technology Holding USA Inc.Fairfield, OH | $108,980 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- Safety Evaluation and Toxicology Studies and Related Services for Drug Development
National Institutes of Health, National Institutes of Health Nida
Award noticeNAICS 541715Albuquerque, NM75N95024D00021Awarded to Lovelace Biomedical Research Institute for $48,622,546
Posted Aug 13, 2024 - Pharmacology Studies and Animal Model Development and Related Services for Drug Development
National Institutes of Health, National Institutes of Health Ncats
Award noticeNAICS 541714Anywhere in the US75N95023R00004-AwardNotice1Awarded to Lovelace Biomedical Research Institute for $48,882,666
Posted Aug 7, 2024
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75F40125P00216Purchase Order, September 19, 2025, Not Competed, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Sole Source Award of a 24-Month Period, Firm Fixed Price (Ffp), Ends Toxicological Studies for Center for Tobacco Products (Ctp).NAICS 541380, PSC B529 | $7,058,882 |
| 75A50123F61001Delivery Order, January 19, 2024, Full and Open Competition | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Radnuc 2201: Performance Verification of Institutional Radiation Dose Response for Acute Radiation Syndrome (Ars) Animal Models (Rodent, RabNAICS 541714, PSC AN13 | $3,918,627 |
| 75A50126F61002Delivery Order, August 21, 2026, Full and Open Competition | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Rtor Bio-Amt-2312: Assessment of the Therapeutic Potential of Chloroquine and Oseltamivir in Two (2) Lethal Models of Influenza a H5N1NAICS 541714, PSC AN13 | $3,723,027 |
| 75N95020F00001Delivery Order, December 20, 2024, Full and Open Competition, 3 offers | National Institutes of Health NidaNational Institutes of Health | Non-Clinical Safety Assessment of Gene Therapy (Pcca, Mmab, DOK7 and Colq) to Support Platform Gene Therapy for Congenital Myasthenic DiseasNAICS 541712, PSC AN11 | $3,028,505 |
| 75F40126F19003Delivery Order, September 14, 2026, Full and Open Competition | FDA Office of Acq Grant SVCSFood and Drug Administration | Nicotine Flux: Investigating the Impact of Ends Output Power and Heating Element on Abuse LiabilityNAICS 541690, PSC B529 | $3,017,553 |
| 75F40119C10161Definitive Contract, March 14, 2024, Full and Open Competition, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Study of E-Cigarette Aerosol Toxicity in in Vivo Nonclinical Models.NAICS 541380, PSC B529 | $2,526,628 |
| 75N95021F00001Delivery Order, October 17, 2024, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Characterization of a Non-Paralyzing Bont-Based Biopharmaceutical for the Treatment of Neuropathic PainNAICS 541715, PSC AN11 | $350,840 |
| 75N98026F00001Delivery Order, September 25, 2026, Full and Open Competition | National Institutes of Health OlaoNational Institutes of Health | GLP Repeat Dose Toxicology Study for a Live-Attenuated Respiratory Virus Vaccine.NAICS 541714, PSC AN42 | $339,534 |
| 75N95023F00002Delivery Order, June 22, 2026, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Efficacy and Safety Evaluation of Lead Gene Therapy Candidate in Neuromuscular Junction (Nmj) Disease Mouse Models and Bioanalytical Assay MNAICS 541715, PSC AN11 | $303,277 |
| W81XWH22P0157Purchase Order, August 1, 2024, Not Competed Under SAP, 1 offers | Army Med Res Acq ActivityDefense Health Agency | Animal Management SoftwareNAICS 511210, PSC DF01 | $267,467 |
| 75N95024F00002Delivery Order, March 20, 2024, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Respiratory Interaction Studies in Rodents, Ability of a Test Article to Reverse the Respiratory Depressant Effects of Opioids. TO5. Period NAICS 541715, PSC AN22 | $211,128 |
| 75N93022F00001Delivery Order, November 14, 2024, Full and Open Competition | National Institutes of Health NiaidNational Institutes of Health | Transfer, Validation and Qualification of Bioanalytical Methods for Detection of Cabotegravir and Levonorgestrel in Rat and Nonhuman PrimateNAICS 541715, PSC AN11 | $193,918 |
| 75N95024F00001Delivery Order, March 20, 2024, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Evaluation of Potential Respiratory Stimulant. TO4. Period of Performance: March 21, 2024 - March 20, 2025.NAICS 541715, PSC AN22 | $140,848 |
| 75N95020F00002Delivery Order, September 17, 2024, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Characterization of a Non-Addictive Small Molecule Therapeutics for the Management of Non-Cancer Pain.NAICS 541715, PSC AN11 | $120,890 |
| 75A50123F61001Delivery Order, February 7, 2024, Full and Open Competition | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Bio-Amt-2301: IDIQ Contract Management Support ActivitiesNAICS 541714, PSC AN13 | $79,841 |
| 75N95020F00004Delivery Order, September 20, 2024, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Characterization of a Downstream Gene Therapeutic for the Reparative Treatment of Severe Fractures.NAICS 541715, PSC AN11 | $53,553 |
| 75N95020F00005Delivery Order, January 9, 2024, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Efficacy and Safety Evaluation of a Lead Gene Therapy Candidate in Propionic Acidemia (Pa) Disease Mouse Models and Bioanalytical Assay MethNAICS 541715, PSC AN11 | $51,059 |
| 75N95022F00001Delivery Order, June 17, 2024, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Bioanalytical Supports for a GLP Tox/Biodistribution Study in Mini-PigsNAICS 541715, PSC AN11 | $44,201 |
| 75N92024P00303Purchase Order, August 27, 2024, Competed Under SAP, 1 offers | National Institutes of Health NhlbiNational Institutes of Health | 24-015894 Nhlbi Population Sciences Branch Requires Pulmonary Function Testing to Determine If the Flexivent Method of Pulmonary Function TeNAICS 541380, PSC Q301 | $16,653 |
| 75N93025D00021September 30, 2025, Full and Open Competition, 37 offersSolicitation | National Institutes of Health NiaidNational Institutes of Health | Evaluation and Testing Services (Ets) for Vaccines and Other Biologics for Infectious Diseases.NAICS 541715, PSC AN11 | $10,000 |
| 75N95024F00001Delivery Order, August 6, 2024, Full and Open Competition, 1 offers | National Institutes of Health NidaNational Institutes of Health | Kick-Off Meeting for the Pharmacology Studies and Animal Model Development and Related Services for Drug Development IDIQ Contract.NAICS 541714, PSC AN12 | $1,000 |
| 75F40122F19001Delivery Order, April 9, 2025, Full and Open Competition, 2 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Increase Clinical Study TimeNAICS 541690, PSC R499 | $0 |
| 75F40123F19001Delivery Order, March 27, 2025, Full and Open Competition | FDA Office of Acq Grant SVCSFood and Drug Administration | Task Order 1 -Title: Are Reductions in Boe, Boph, and Other Health Risk Markers Proportional to Reductions in Cigarette Smoking Upon SwitchiNAICS 541690, PSC B529 | $0 |
| 75F40123F19002Delivery Order, March 26, 2025, Full and Open Competition | FDA Office of Acq Grant SVCSFood and Drug Administration | Task Order 2 - Examining the Influence of Synthetic Cooling Agents on Cigarette Sensory and Subjective Effects and Use BehaviorNAICS 541690, PSC B529 | $0 |
| 75N95020F00003Delivery Order, December 17, 2024, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Natural History Studies in Neuromuscular Junction (Nmj) Disease Mouse Models.NAICS 541715, PSC AN11 | $0 |
| 75N95023F00001Delivery Order, May 8, 2024, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Characterization of Spontaneous Osteogenesis After Surgical Segmental Bone Defect in a Large AnimalNAICS 541715, PSC AN11 | $0 |
| 75A50122D00008April 2, 2024, Full and Open Competition, 5 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Lovelace Biomedical Research Institute(Chem) - IDIQ for Barda CRN Animal Model DevelopmentNAICS 541714, PSC AN13 | $0 |
| 75A50122D00013January 18, 2024, Full and Open Competition, 4 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Lovelace Biomedical Research Institute (Radnuc) - IDIQ for Barda CRN Animal Model DevelopmentNAICS 541714, PSC AN13 | $0 |
| 75F40123D00039February 23, 2026, Full and Open Competition, 1 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | Award of Five-Year IDIQ for Ctp- Assessing Tobacco-Related Clinical Outcomes and Human Behaviors in TobaccoNAICS 541690, PSC B529 | $0 |
| 75N92019D00017June 14, 2024, Full and Open Competition, 1 offers | National Institutes of Health NhlbiNational Institutes of Health | Gene Therapy Resource Program (Gtrp): Pharmacology and Toxicology Core LaboratoryNAICS 541714, PSC AN11 | $0 |
| 75N93021D00031March 11, 2026, Full and Open Competition, 29 offers | National Institutes of Health NiaidNational Institutes of Health | Comprehensive and Rapid Response for Niaid Research ProgramsNAICS 541714, PSC AN42 | $0 |
| 75N93022D00009November 15, 2024, Full and Open Competition, 3 offers | National Institutes of Health NiaidNational Institutes of Health | The Contractor Shall Provide Preclinical Development Support for Candidate Products and Drug Development Activities.NAICS 541715, PSC AN11 | $0 |
| 75N93023D00004July 15, 2026, Full and Open Competition, 4 offers | National Institutes of Health NiaidNational Institutes of Health | Eo 14398NAICS 541715, PSC AN11 | $0 |
| 75N95019D00030April 28, 2025, Full and Open Competition, 13 offers | National Institutes of Health NidaNational Institutes of Health | Eoi::implementing the Presidents Department of Government Efficiency Cost Efficiency Initiative (March 19, 2025)::EOI Notice of Termination NAICS 541715, PSC AN11 | $0 |
| 75N95022D00019July 23, 2024, Full and Open Competition, 4 offers | National Institutes of Health NidaNational Institutes of Health | Assessment of Potential Treatments for Drug-Induced Respiratory Depression and Overdose Toxicity. Ordering Period: September 26, 2022 - SeptNAICS 541715, PSC AN22 | $0 |
| 75N95024D00021June 20, 2024, Full and Open Competition, 6 offersSolicitation | National Institutes of Health NidaNational Institutes of Health | Safety Evaluation and Toxicology Studies and Related Services for Drug DevelopmentNAICS 541715, PSC AN11 | $0 |
| 75N95024D00027August 6, 2024, Full and Open Competition, 2 offersSolicitation | National Institutes of Health NidaNational Institutes of Health | Pharmacology Studies and Animal Model Development and Related Services for Drug DevelopmentNAICS 541714, PSC AN12 | $0 |
| HHSF223201510001IJuly 28, 2026, Full and Open Competition, 4 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | In Vitro Toxicology of Tobacco and Related ProductsNAICS 541712, PSC AJ11 | $0 |
| HT001122D0030October 16, 2024, Full and Open Competition, 126 offers | Defense Health AgencyDefense Health Agency | Omnibus IV Military Medical Research and Development.NAICS 541714, PSC AN14 | $0 |
| W81XWH17C0235Definitive Contract, March 5, 2024, Not Competed, 1 offers | W4PZ USA Med RSCH Acquis ActDepartment of the Army | Non-Personal Services for Maintenance of the Animal Monitoring System for the Walter Reed Army Institute of Research.NAICS 511210, PSC D399 | -$0 |
| 75N93021F00001Delivery Order, September 15, 2026, Full and Open Competition | National Institutes of Health NiaidNational Institutes of Health | To Administratively De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in PreparatiNAICS 541714, PSC AN42 | -$2,000 |
| 75N92024F00001Delivery Order, July 18, 2024, Full and Open Competition | National Institutes of Health NhlbiNational Institutes of Health | Gene Therapy Resource Program (Gtrp): Pharmacology and Toxicology Core Laboratory - Task Area A: Core Administrative ActivitiesNAICS 541714, PSC AN11 | -$7,213 |
| 75N92021F00001Delivery Order, March 29, 2024, Full and Open Competition | National Institutes of Health NhlbiNational Institutes of Health | Gene Therapy Resource Program (Gtrp): Pharmacology/Toxicology Core Laboratory - Scientific Project for Rsa No. 2057 (Rader)NAICS 541714, PSC AN11 | -$28,989 |
| 75N92023F00001Delivery Order, July 9, 2024, Full and Open Competition | National Institutes of Health NhlbiNational Institutes of Health | Gene Therapy Resource Program (Gtrp): Pharmacology and Toxicology Core LaboratoryNAICS 541714, PSC AN11 | -$62,736 |
| 75N95019F00090Delivery Order, June 28, 2024, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Change the Cor Listed Under H. Contracting Officer'S Representative and Program Office Pocs.NAICS 541715, PSC AN11 | -$63,192 |
| 75N93019F00131Delivery Order, July 8, 2024, Full and Open Competition, 1 offers | National Institutes of Health NiaidNational Institutes of Health | Transfer and Validation of Bioanalytical Method for Detection of Cabotegravir in Rat PlasmaNAICS 541712, PSC AN81 | -$93,712 |
| 75N92022F00001Delivery Order, March 29, 2024, Full and Open Competition | National Institutes of Health NhlbiNational Institutes of Health | Gene Therapy Resource Program (Gtrp): Pharmacology and Toxicology Core LaboratoryNAICS 541714, PSC AN11 | -$110,621 |
| 75N95019F00089Delivery Order, May 6, 2024, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Evaluation of Drug Efficacy in a Guinea Pig Model of Neonatal Opioid Withdrawal Syndrome. the Period of Performance of This Task Order Was SNAICS 541715, PSC AN11 | -$150,986 |
| 75N95018F00002Delivery Order, February 28, 2024, Full and Open Competition, 2 offers | National Institutes of Health NidaNational Institutes of Health | Non-Clinical Safety Assessment of Tthx1114 to Support Fuchs Endothelial Corneal Dystrophy Ind Application. Pop: September 17, 2018 to OctobeNAICS 541712, PSC AN11 | -$156,237 |
| 75N95019F00088Delivery Order, June 28, 2024, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Disease Model Characterization and Development of Assays to Evaluate and Measure Pain in a Porcine Model for Sickle Cell Disease (Scd).NAICS 541715, PSC AN11 | -$165,600 |
| 75N95021F00002Delivery Order, May 7, 2025, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Eoi::hhs Cost Efficiency Initiative::eoi Partial Termination for Convenience - DescopeNAICS 541715, PSC AN11 | -$170,952 |
| 75N95020F00001Delivery Order, November 14, 2024, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Pharmacodynamics of the Mas-Related Gene X2 (Mrgx2) Antagonist SYR268215 in the Humanized Mrgx2 Knock-In (Ki) MouseNAICS 541715, PSC AN11 | -$174,821 |
| 75N92020F00002Delivery Order, May 20, 2025, Full and Open Competition | National Institutes of Health NhlbiNational Institutes of Health | Gene Therapy Resource Program (Gtrp): Pharmacology/Toxicology Core LaboratoryNAICS 541714, PSC AN11 | -$480,276 |
| 75N92019F00074Delivery Order, May 10, 2024, Full and Open Competition | National Institutes of Health NhlbiNational Institutes of Health | Gene Therapy Resource Program (Gtrp): Pharmacology and Toxicology Core Laboratory Scientific ActivitiesNAICS 541714, PSC AN11 | -$725,129 |
| 75A50120F33002Delivery Order, September 19, 2024, Full and Open Competition, 6 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Project Rtor Bio-Amt-1021: Development of Animal Models for Evaluation of Medical Countermeasures for Sars-Cov-2NAICS 541711, PSC AN13 | -$1,363,328 |
- Places of performance
- New MexicoMaryland
- Product and service codes
- B529 Scientific Data StudiesAN13 Health R&D Services; Health Care Services; Experimental DevelopmentAN11 Health R&D Services; Health Care Services; Basic ResearchAN22 Health R&D Services; Health Research And Training; Applied ResearchAN42 Health R&D Services; Health Care - Other; Applied ResearchDF01 Support services for IT Management to include Enterprise Architecture (EA), Financial Management, and Strategic Planning. EA includes services supporting business, information, application and technical architecture to drive standardization, integration and efficiency among business technology solutions. Financial Management includes services involved in the planning, budgeting, spend management and chargeback of IT expenditures and the costing of IT products and services. IT Management and Strategic Planning include senior professional and administrative support services facilitating centralized IT strategy and planning.
- Transactions
- 120 across 55 awards